Anti-tumor effect of internal image bearing anti-idiotypic monoclonal antibody in relation to GM3 ganglioside

International Journal of Cancer

Volumn 76, Issue 3, 1998, Pages 345-353

  Jinnohara, Tsuneharu ^a   Tsujisaki, Masayuki ^b   Sasaki, Shigeru ^a   Hinoda, Yuji ^a   Taniguchi, Masaru ^c   Imai, Kohzoh ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Tenshi Hospital   (Japan)

^c CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIIDIOTYPIC ANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; GANGLIOSIDE GM3; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY D704; MONOCLONAL ANTIBODY M2590; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CANCER SURVIVAL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; MELANOMA; MELANOMA CELL; MIXED LYMPHOCYTE CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; FEMALE; G(M3) GANGLIOSIDE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TREATMENT OUTCOME; TUMOR CELLS, CULTURED;

EID: 0031779158     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980504)76:3<345::AID-IJC11>3.0.CO;2-A     Document Type: Article

References (21)

1. ANDREW, J.T., GEORGE, A.J., FOLKARD, S.G., HAUBLIN, T.J. and STEVENSON, F.K., Idiotypic vaccination as a treatment for a B cell lymphoma. J. Immunol., 141, 2168-2174 (1988).
2. DENTON, G.W.L., DURRANT, L.G., HARDCASTLE, J.D., AUSTIN, E.B. and ROBINS, R.A., Clinical outcome of colorectal cancer patients treated with human monoclonal anti-idiotypic antibody. Int. J. Cancer, 57, 10-14 (1994).
3. DUNN, C.P.L., JOHNSON, C.A., STYLES, J.M., PEASE, S.S. and DEAN, C.J., Vaccination with syngeneic monoclonal anti-idiotype protects against a tumor challenge. Immunology, 60, 181-186 (1987).
4. DURRANT, L.G., DORAN.M., AUSTIN, E.B. and ROBINS, R.A., Induction of cellular immune responses by a murine monoclonal anti-idiotypic antibody recognizing the 791Tgp72 antigen expressed on colorectal, gastric and ovarian human tumours. Int. J. Cancer, 61, 62-66 (1995).
5. FIELDS, B.A., GOLDBAUM, F.A., YSERN, X., POLJAK, R.J. and MARIUZZA, R.A., Molecular basis of antigen mimicry by an anti-idiotope. Nature (Lond.), 374, 739-742 (1995).
6. - T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity. J. Immunol., 133, 1671-1676 (1984).
7. GREER, J.M. and HALLIDAY, W.J., Effects of anti-idiotype vaccine on tumour growth and on production of soluble factors modulating cellmediated immunity in vitro. Cancer Immunol. Immunother., 33, 171-176 (1991).
8. HERLYN, D., BENDEN, A., KANE, M., SOMASUNDARAM, R., ZALOUDIK, J., SPERLAGH, M., MARKS, G., HART, E., RALPH, C., WETTENDORFF, M. and MASTRANGELO, M., Anti-idiotypic cancer vaccines: pre-clinical and clinical studies. In Vivo, 5, 615-624 (1991).
9. 2 ganglioside. J. clin. Oncol., 12, 1036-1044 (1994).
10. MARUYAMA, H., BENDEN, A., LI, W., ZALOUDIK, J., KOIDO, T., TAUPIN, J.L., ACRES, B., SOMASUNDARAM, R., PREWETT, M. and HERLYN, D., Monoclonal anti-idiotypic antibody functionally mimics the human gastrointestinal carcinoma epitope GA733. Int. J. Cancer. 65, 547-553 (1996).
11. MITTELMAN, A., CHEN, Z.J., LIU, C.C., HIRAI, S. and FERRONE, S., Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23. Cancer Res., 54, 415-421 (1994).
12. MOTELMAN, A., CHEN, Z.J., YANG, H., WONG, G.Y. and FERRONE, S., Human high molecular weight melanoma-associated antigen (HMWMAA) mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: Induction of humoral anti-HMW-MAA immunity and prolongation of survival in patients with stage IV melanoma. Proc. nat. Acad. Sci. (Wash.), 89, 466-470 (1992).
13. MOSMANN, T.R. and COFFMAN, R.L., TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann. Rev. Immunol., 7, 145-173 (1989).
14. - cytotoxic T-lymphocytes. Cancer Res., 48, 2730-2733 (1988).
15. 2. J. Immunol., 145, 760-767 (1990).
16. RAYCHAUDHURI, S., SAEKI, Y., CHEN, J.J., IRIBE, H., FUJI, H. and KÖHLER, H., Tumor-specific idiotype vaccine II. Analysis of the tumor-related network response induced by the tumor and by internal image antigens (Ab2 β). J. Immunol., 139, 271-278 (1987).
17. SOMASUNDARAM, R., ZALOUDIK, J., JACOB, L., BENDEN, A., SPERLAGH, M., HART, E., MARKS, G., KANE, M., MASTRANGELO, M. and HERLYN, D., Induction of antigen-specific T and B cell immunity in colon carcinoma patients by anti-idiotypic antibody. J. Immunol., 155, 3253-3261 (1995).
18. SUZUKI, M., IWASHIRO, M., TAKATSUKI, F., KURIBAYASHI, K. and HAMURO, J., Reconstitution of anti-tumor effects of lentinan in nude mice: role of delayed-type hypersensitivity reaction triggered by CD4-positive T cell clone in the infiltration of effector cells into tumor. Jpn. J. Cancer Res., 85, 409-417 (1994).
19. TOMAYKO, M.M. and RAYNOLDS, C.P., Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother. Pharmacol., 24, 148-154 (1989).
20. TSUJISAKI, M., HINODA, Y., TOKUCHI, S., HANZAWA, Y., ARIMURA, Y., MASUYA, J., KITAGAWA, H., OKOCHI, E., SHIMAMURA, T., HAMURO, J., IMAI, K. and YACHI, A., The analysis of internal image-bearing anti-idiotypic monoclonal antibody in relation to carcinoembryonic antigen. J. Immunol., 150, 508-516 (1993).
21. TSUJISAKI, M., IMAI, K., TOKUCHI, S., HANZAWA, Y., ISHIDA, T., KITAGAWA, H., HINODA, Y. and YACHI, A., Induction of antigen-specific immune response with use of anti-idiotypic monoclonal antibodies to anticarcinoembryonic antigen antibodies. Cancer Res., 51, 2599-2604 (1991).